Cerus Corporation (CERS): Price and Financial Metrics

CERS POWR Grades

• CERS scores best on the Growth dimension, with a Growth rank ahead of 94.49% of US stocks.
• CERS's strongest trending metric is Quality; it's been moving down over the last 177 days.
• CERS ranks lowest in Momentum; there it ranks in the 10th percentile.

CERS Stock Summary

• CERUS CORP's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than 86.52% of US listed stocks.
• Over the past twelve months, CERS has reported earnings growth of 27.36%, putting it ahead of 74.43% of US stocks in our set.
• The volatility of CERUS CORP's share price is greater than that of 80.81% US stocks with at least 200 days of trading history.
• Stocks with similar financial metrics, market capitalization, and price volatility to CERUS CORP are LCTX, APLS, OMIC, TVTX, and FCEL.
• Visit CERS's SEC page to see the company's official filings. To visit the company's web site, go to www.cerus.com.

CERS Valuation Summary

• CERS's EV/EBIT ratio is -9.7; this is 176.38% lower than that of the median Healthcare stock.
• CERS's price/sales ratio has moved down 8.2 over the prior 243 months.

Below are key valuation metrics over time for CERS.

CERS Growth Metrics

Its 3 year net cashflow from operations growth rate is now at 13.22%.
• The 2 year net cashflow from operations growth rate now stands at 41.06%.
• Its year over year net income to common stockholders growth rate is now at 19.14%.

CERS's revenue has moved up $112,651,000 over the prior 49 months.

The table below shows CERS's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-09-30	187.082	-25.081	-38.274
2022-06-30	182.84	-29.605	-42.229
2022-03-31	172.972	-37.402	-49.201
2021-12-31	159.518	-33.922	-54.374
2021-09-30	143.02	-41.158	-59.636
2021-06-30	130.11	-39.255	-61.338

CERS's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• CERS has a Quality Grade of C, ranking ahead of 39.02% of graded US stocks.
• CERS's asset turnover comes in at 0.647 -- ranking 61st of 186 Medical Equipment stocks.
• BSGM, NVCR, and STRR are the stocks whose asset turnover ratios are most correlated with CERS.

The table below shows CERS's key quality metrics over time.